A medical technology company that develops devices to reduce the risk of brain lesions and stroke during cardiology procedures such as transcatheter aortic valve replacement.
Protembis has raised €59M across 3 funding rounds from 10 investors, most recently a Debt round in Jul 2024. Based in Aachen, Germany; founded 2013; active in Healthtech. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2024-07-30 | Debt | €20M | The European Investment Bank (EIB) | View deal → |
| 2024-03-26 | Series B | €30M | Angel Investors,Coparion,Family Offices,Segulah Medical Acceleration,TechVision Fund,XGEN Venture | View deal → |
| 2018-10-01 | Series A | €8.6M | Abiomed Inc.,coparion,Seed Fonds III | View deal → |
